Facility for Targeted Radiometals in Cancer (AFTRiC)

The University of Queensland

The Australian Cancer Research Foundation (ACRF) Facility for Targeted Radiometals in Cancer (AFTRiC) enables research focused on discovering better ways of specifically targeting and delivering therapeutic payloads to cancer cells, measuring their effects on tissue and translating them into clinical use. AFTRiC includes equipment and instrumentation to enable development of new targeted alpha therapies. Alpha therapies have the potential to deliver greater cancer killing effect with less damage to healthy tissues.

AFTRiC was established through investment by the Australian Cancer Research Foundation, National Imaging Facility under the Australian Government's National Collaborative Research Infrastructure Team and the Ian Potter Foundation.

Website

https://aibn.uq.edu.au/article/2023/09/cai-launches-3m-facility-unlock-cancer-treatment-potential

Organisation type

• Research Infrastructure Co-investment Fund facility

Number of research staff

Up to 20 research staff

Address

Centre for Advanced Imaging, Building 57, The University of Queensland, St Lucia QLD 4072

Strengths and capabilities

• radiometal production
• in vivo pharmokinetics and biodistribution of targeted alpha therapies
• biomedical imaging

Facilities and major equipment

• Hot Cells
• Cyclotron targetry for production of Ga-68, Zr-89, Tc-99, Cu-64
• Pre-clinical SPECT-CT

Key science sectors

More information about the sectors this centre is involved in:

• Biotechnology
• Health and medical